Advisor Partners II’s Idexx Laboratories IDXX Stock Holding History

Advisor Partners II’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.99M	Buy	4,542 +214	+5%	+$107K	0.08%	273
2023 Q2	$2.17M	Buy	4,328 +163	+4%	+$78.1K	0.1%	192
2023 Q1	$2.08M	Buy	4,165 +278	+7%	+$133K	0.11%	181
2022 Q4	$1.59M	Buy	3,887 +1,340	+53%	+$520K	0.1%	230
2022 Q3	$830K	Buy	+2,547	New	+$936K	0.06%	316

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Advisor Partners II's IDXX Position: Q3 2023 in Review

Advisor Partners II increased its Idexx Laboratories (IDXX) stake by 4.9% in Q3 2023, buying an estimated $107K and bringing the position to 4,542 shares worth $1.99M. The position accounts for 0.08% of the portfolio, ranked #273.

Advisor Partners II first reported a position in IDXX in Q3 2022 and has held it in 5 quarters since. The position peaked at $2.17M in Q2 2023. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

Advisor Partners II held 4,542 shares of Idexx Laboratories worth $1.99M as of Q3 2023.
Advisor Partners II bought 214 Idexx Laboratories shares in Q3 2023, an estimated $107K.
Idexx Laboratories made up 0.08% of Advisor Partners II's portfolio in Q3 2023, its #273 holding.
Advisor Partners II first reported a position in Idexx Laboratories in Q3 2022 and has held it in 5 quarters since.
Advisor Partners II's Idexx Laboratories position peaked at $2.17M in Q2 2023.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.